XORTX Therapeutics Inc.
|
|||
| Mailing Address: | 3710 - 33rd Street NW Calgary, AB T2L 2M1 |
Head Office Address: | 3710 - 33rd Street NW Calgary, AB T2L 2M1 |
| Contact Name: | Allen Davidoff | Principal Regulator: | Alberta |
| Business e-mail address: | adavidoff@xortx.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 403 607-2621 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario |
| Fax Number: | 403 260-3501 | Stock Exchange: | NASDAQ, TSX Venture |
| Date of Formation: | May 31 2011 | Stock Symbol: | XRTX |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Smythe LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 98420Q | Transfer Agent: | TSX Trust Company |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
